federal_register: 2010-15352

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2010-15352 Dermatologic and Ophthalmic Drugs Advisory Committee; Cancellation Notice The meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for June 28, 2010, is cancelled. This meeting was announced in the Federal Register of May 11, 2010 (75 FR 26264). The meeting was to discuss new drug application (NDA) 22-340, voclosporin 10-milligram capsules, by Lux Biosciences Inc. This meeting has been cancelled to allow time for the resolution of several outstanding issues. The agency intends to continue evaluating NDA 22-340 and, as needed, may schedule an advisory committee meeting in the future. 2010-06-24 2010 6 https://www.federalregister.gov/documents/2010/06/24/2010-15352/dermatologic-and-ophthalmic-drugs-advisory-committee-cancellation https://www.govinfo.gov/content/pkg/FR-2010-06-24/pdf/2010-15352.pdf Health and Human Services Department; Food and Drug Administration 221,199 The meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for June 28, 2010, is cancelled. This meeting was announced in the Federal Register of May 11, 2010 (75 FR 26264). The meeting was to discuss new drug application (NDA)...  

Links from other tables